Arcus Biosciences Inc (RCUS)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 462,000 | 657,000 | 842,000 | 502,000 | 164,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $462,000K)
= 0.00
The debt-to-capital ratio of Arcus Biosciences Inc has consistently been 0.00 over the past five years, indicating that the company has not utilized debt as a source of capital during this period. This implies that the company has relied solely on equity financing to fund its operations and growth. A debt-to-capital ratio of 0.00 typically indicates a conservative financial strategy, as the company is not burdened by interest payments and debt obligations. However, it is important to note that having no debt can also limit financial flexibility and tax benefits associated with debt financing. Overall, Arcus Biosciences Inc's consistent 0.00 debt-to-capital ratio suggests a low-risk capital structure but may also reflect a missed opportunity to leverage debt for potential growth and tax advantages.
Peer comparison
Dec 31, 2023